ViiV vows joint venture will help fight HIV

Nov 3, 2009 3 related
 

The new head of the pioneering HIV joint venture between GlaxoSmithKline and Pfizer predicts his company can operate for at least five years without fresh funding from its shareholders. Dominique Limet, chief executive of ViiV... [read full story]                    

powered by
Add Comment
There are also 3 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies